Contraception

FDA postpones morning-after pill decision

Published in Medical Letter on the CDC and FDA, March 14th, 2004

Under strong political pressure to reject over-the-counter sales of a morning-after birth control pill, the U.S. Food and Drug Administration (FDA) is postponing its decision until May 2004.

A ruling had been expected in February 2004 on the pills, called Plan B, made by Barr Laboratories. The company announced on February 13 that the FDA is delaying action for 90 days on Barr's request to sell Plan B without prescriptions to give time to seek more detailed information on use of the pills by 16- and 17-year-old girls.

The agency needs more time to evaluate that information, Barr spokeswoman Carol Cox said. "It's not that unusual that they'd request...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2004-03-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry